Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Tigecycline (Primary)
- Indications Acinetobacter infections
- Focus Therapeutic Use
- 16 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 30 Apr 2011 New trial record